Sec. 17b-491b. Reimbursement formula for drugs used to treat hemophilia A.
Sec. 17b-491b. Reimbursement formula for drugs used to treat hemophilia A.
The maximum allowable cost paid for Factor VIII pharmaceuticals under the Medicaid,
state-administered general assistance, and ConnPACE programs shall be the actual acquisition cost plus eight per cent. The Commissioner of Social Services may designate
specific suppliers of Factor VIII pharmaceuticals from which a dispensing pharmacy
shall order the prescription to be delivered to the pharmacy and billed by the supplier
to the Department of Social Services. If the commissioner so designates specific suppliers of Factor VIII pharmaceuticals, the department shall pay the dispensing pharmacy
a handling fee equal to eight per cent of the actual acquisition cost for such prescription.
(June Sp. Sess. P.A. 00-2, S. 35, 53; P.A. 04-76, S. 22.)
History: June Sp. Sess. P.A. 00-2 effective July 1, 2000; P.A. 04-76 deleted reference to "general assistance".